Impact of Adjuvant Radiotherapy on Survival after Pancreatic Cancer Resection: An Appraisal of Data from the National Cancer Data Base

Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease

(2011) K. A. Bickenbach et al.   ANNALS OF SURGICAL ONCOLOGY

Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial

(2011) William F. Regine et al.   ANNALS OF SURGICAL ONCOLOGY

Management of Patients with Pancreatic Adenocarcinoma: National Trends in Patient Selection, Operative Management, and Use of Adjuvant Therapy

(2011) Skye C. Mayo et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study

(2010) Charles C. Hsu et al.   ANNALS OF SURGICAL ONCOLOGY

Progress for resectable cancer?

(2010) Jessica P. Simons et al.   CANCER

A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma

(2010) Theodore P. McDade et al.   CANCER

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma

(2010) Jerome Landry et al.   JOURNAL OF SURGICAL ONCOLOGY

Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review

(2009) R. Le Scodan et al.   ANNALS OF ONCOLOGY

Challenges in the Study of Adjuvant Chemoradiation After Pancreaticoduodenectomy

(2009) Christopher H. Crane et al.   ANNALS OF SURGICAL ONCOLOGY

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

(2009) J P Neoptolemos et al.   BRITISH JOURNAL OF CANCER